Automated insulin delivery systems are safe, effective, and well-received by older adults with type 1 diabetes, challenging ...

The Vietnam Insulin Patch Pumps Market was valued at USD 8.47 Million in 2024 and is projected to reach USD 14.68 Million by 2030, exhibiting a CAGR of 9.56% during the forecast period. The market is ...

Caring for a baby is a full-time job, often causing new mothers to overlook their own health needs. This situation is ...

Kashmiri doctor and columnist Dr Tasaduk Hussain Itoo has been honored with the prestigious Indian Achievers Award 2025 for ...

A grant from the U.S. Department of Veterans Affairs (VA) will aid Wayne State University researchers in finding new insights into diabetes and its onset.

There are several domestic drug companies that seem to be all prepared to transform diabetes therapy with the launch of the ...

A study reveals the 1-hour OGTT is a stronger, more convenient predictor of postpartum dysglycaemia than the 2-hour test.

With the expiration of Boehringer Ingelheim’s patent on Empagliflozin, several Indian pharmaceutical companies are set to ...

As of 2023, India is home to approximately 77 million adults living with diabetes, according to the International Diabetes ...

Domestic drug companies in India are preparing to launch affordable generics of the diabetes drug Empagliflozin after the ...

While Metformin continues to be the standard first-line treatment for Type-2 diabetes, newer therapies such as SGLT2 ...